Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2

被引:24
作者
Johnson, Kyle B. [1 ]
Petersen-Jones, Humphrey [1 ]
Thompson, Janice M. [1 ]
Hitomi, Kiyotaka [2 ]
Itoh, Miho [2 ]
Bakker, Erik N. T. P. [3 ]
Johnson, Gail V. W. [4 ]
Colak, Gozde [4 ]
Watts, Stephanie W. [1 ]
机构
[1] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA
[2] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan
[3] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Rochester, Dept Anesthesiol, Rochester, NY USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2012年 / 302卷 / 07期
关键词
protein cross-linking; amidation; vascular disease; TISSUE TRANSGLUTAMINASE; FACTOR-XIII; CROSS-LINKING; SEROTONYLATION; STABILIZATION; DEFICIENT; CYSTAMINE; SYSTEM; MICE;
D O I
10.1152/ajpheart.00918.2011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Johnson KB, Petersen-Jones H, Thompson JM, Hitomi K, Itoh M, Bakker ENTP, Johnson GV, Colak G, Watts SW. Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2. Am J Physiol Heart Circ Physiol 302: H1355-H1366, 2012. First published February 3, 2012; doi: 10.1152/ajpheart.00918.2011.-Transglutaminase (TG) function facilitates several vascular processes and diseases. Although many of these TG-dependent vascular processes have been ascribed to the function of TG2, TG2 knockout mice have a mild vascular phenotype. We hypothesized that TGs besides TG2 exist and function in the vasculature. Biotin-pentylamide incorporation, a measure of general TG activity, was similar in wild-type and TG2 knockout mouse aortae, and the general TG inhibitor cystamine reduced biotin-pentylamine incorporation to a greater extent than the TG2-specific inhibitor Z-DON, indicating the presence of other functional TGs. Additionally, 5-hydroxytryptamine-induced aortic contraction, a TG-activity-dependent process, was decreased to a greater extent by general TG inhibitors vs. Z-DON (maximum contraction: cystamine = abolished, monodansylcadaverine = 28.6 +/- 14.9%, and Z-DON = 60.2 +/- 15.2% vehicle), providing evidence for the importance of TG2-independent activity in the vasculature. TG1, TG2, TG4, and Factor XIII (FXIII) mRNA in rat aortae and vena cavae was detected by RT-PCR. Western analysis detected TG1 and TG4, but not FXIII, in rat aortae and vena cavae and in TG2 knockout and wild-type mouse aortae. Immunostaining confirmed the presence of TG1, TG2, and TG4 in rat aortae and vena cavae, notably in smooth muscle cells; FXIII was absent. K5 and T26, FITC-labeled peptide substrates specific for active TG1 and TG2, respectively, were incorporated into rat aortae and vena cavae and wild-type, but not TG2 knockout, mouse aortae. These studies demonstrate that TG2-independent TG activity exists in the vasculature and that TG1 and TG4 are expressed in vascular tissues.
引用
收藏
页码:H1355 / H1366
页数:12
相关论文
共 39 条
[1]   The protective effects of cystamine in the R6/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminase [J].
Bailey, Craig D. C. ;
Johnson, Gail V. W. .
NEUROBIOLOGY OF AGING, 2006, 27 (06) :871-879
[2]   Small artery remodeling depends on tissue-type transglutaminase [J].
Bakker, ENTP ;
Buus, CL ;
Spaan, JAE ;
Perree, J ;
Ganga, A ;
Rolf, TM ;
Sorop, O ;
Bramsen, LH ;
Mulvany, MJ ;
VanBavel, E .
CIRCULATION RESEARCH, 2005, 96 (01) :119-126
[3]   Transglutaminases in vascular biology: Relevance for vascular remodeling and atherosclerosis [J].
Bakker, Erik N. T. P. ;
Pistea, Adrian ;
VanBavel, Ed .
JOURNAL OF VASCULAR RESEARCH, 2008, 45 (04) :271-278
[4]   Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase - Possible compensation by macrophage-derived factor XIII [J].
Bakker, Erik N. T. P. ;
Pistea, Adrian ;
Spaan, Jos A. E. ;
Rolf, Titia ;
de Vries, Carlie J. ;
van Rooijen, Nico ;
Candi, Eleonara ;
VanBavel, Ed .
CIRCULATION RESEARCH, 2006, 99 (01) :86-92
[5]   Role of transglutaminase 1 in stabilisation of intercellular junctions of the vascular endothelium [J].
Baumgartner, W ;
Golenhofen, N ;
Weth, A ;
Hiiragi, T ;
Saint, R ;
Griffin, M ;
Drenckhahn, D .
HISTOCHEMISTRY AND CELL BIOLOGY, 2004, 122 (01) :17-25
[6]   Transglutaminase 1 stabilizes β-actin in endothelial cells correlating with a stabilization of intercellular junctions [J].
Baumgartner, Werner ;
Weth, Agnes .
JOURNAL OF VASCULAR RESEARCH, 2007, 44 (03) :234-240
[7]   Differential alternative splicing of human transglutaminase 4 in benign prostate hyperplasia and prostate cancer [J].
Choi, Sung-Yup ;
Choi, Kyungho ;
Jeon, Ju-Hong ;
Kim, Chai-Wan ;
Shin, Dong-Myung ;
Lee, Jong Bouk ;
Lee, Sang Eun ;
Kim, Choung-Soo ;
Park, Jeong-Soo ;
Jeong, Eui Man ;
Jang, Gi-Yong ;
Song, Kye-Yong ;
Kim, In-Gyu .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2010, 42 (04) :310-318
[8]   Factor XIII (FXIII) and angiogenesis [J].
Dardik, R ;
Loscalzo, J ;
Inbal, A .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) :19-25
[9]  
DAVIES PJA, 1984, DIABETES CARE, V7, P35
[10]   Gene disruption of tissue transglutaminase [J].
De Laurenzi, V ;
Melino, G .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (01) :148-155